Source: International Congress 2018 – ILDs: From bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ishii (Tokyo, Japan), R. Tazawa (Niigata, Japan), T. Saraya (Tokyo, Japan), Y. Inoue (Osaka, Japan), K. Nakata (Niigata, Japan). Late Breaking Abstract - Prognostic analysis of secondary pulmonary alveolar proteinosis: Inspection by one of the world’s largest data.. 265

Member's Comments

No comment yet.

Related content which might interest you: Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey. Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Covid-19 management in an Italian Prison. Monitoring of pulmonary function using oscillometry. Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases Source: International Congress 2016 – Orphan diseases I Year: 2016 Pulmonary alveolar proteinosis – Gender differences in a 20 cases analysis in a reference institute in Romania Source: International Congress 2014 – ILDs 3 Year: 2014 Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Source: Eur Respir J 2011; 37: 465 Year: 2011 Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR) Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Late Breaking Abstract - Pulmonary embolism in patients admitted by COVID-19. Incidence and features. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Late Breaking Abstract - Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from  ATLANTIS Study Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Late Breaking Abstract - Characteristics of Post-COVID-19 interstitial lung syndrome in Bronchoalveolar Lavage: Preliminary results. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - COVID-19 epidemic in Respiratory Diseases Unit: partioning analysis and data mining. Results from a single Institution experience. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Pulmonary alveolar proteinosis: A case report Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020